Vagina cancer in a young woman exposed to diethylstilbestrol: Case report and literature review;Cáncer de vagina en una mujer joven expuesta a dietilestilbestrol: Caso clínico y revisión de la bibliografía

Ginecologia y Obstetricia de Mexico

Volumn 73, Issue 12, 2005, Pages 666-673

  Novoa Vargas, Arturo ^b   Grados García, Conrado ^a   Bustillos De Cima, Roberto ^a   Malagón Millán, Berenice ^a  

^a Hospital de Ginecoobstetricia y Perinatología Dr Río de la Loza

^b NONE

Author keywords

Clear cell vaginal cancer; Diethylstilbestrol

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DIETHYLSTILBESTROL; EPIRUBICIN; ANTINEOPLASTIC AGENT;

ADENOCARCINOMA; ADULT; BIOPSY TECHNIQUE; CANCER STAGING; CANCER SUSCEPTIBILITY; CASE REPORT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LAPAROTOMY; LYMPH NODE METASTASIS; PROGNOSIS; REVIEW; VAGINA CARCINOMA; ABDOMINAL RADIOGRAPHY; ADJUVANT CHEMOTHERAPY; ARTICLE; BIOPSY; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; PATHOLOGY; PREGNANCY; PRENATAL EXPOSURE; RADIOGRAPHY; TIME; VAGINA; VAGINA TUMOR;

ADENOCARCINOMA, CLEAR CELL; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; CHEMOTHERAPY, ADJUVANT; DIETHYLSTILBESTROL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; LYMPHATIC METASTASIS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROGNOSIS; RADIOGRAPHY, ABDOMINAL; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; VAGINA; VAGINAL NEOPLASMS;

EID: 33645890582     PISSN: 03009041     EISSN: 03009041     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. th ed. Lippincott Williams and Wilkins, 2001;pp:1550-6.
2. Trimble EL. A guest editorial: update on diethylstilbestrol. Obstet Gynecol Surv 2001;56(4):187-9.
3. Kirkbride P, Fyles A, Rawlings GA, Anchul Lewin W, Murphy KC, Simm J. Carcinoma of the vagina, experience at the Princess Margaret Hospital (1974-1989). Gynecol Oncol 1995;56:435-43.
4. Steed HL, Pearcey RG, Capstick V, Honore LH. Invasive squamous cell carcinoma of the vagina during pregnancy. Obstet Gynecol 2002;100(5 Pt2):1105-8.
5. Giusti RM, Iwamoto K, Hatch EE. Diethylstilbestrol revisited: a review of the long-term health effects. Ann Intern Med 1995;122:778-88.
6. William H. Natcher Center. Featured report. DES research update 1999: current knowledge, future directions. Bethesda: National Institutes of Health (NIH), 1999;pp:19-20.
7. Faber K, Jones M, Terraza MH Jr. Invasive squamous cell carcinoma of the vagina in a diethylstilbestrol-exposed woman. Gynecol Oncol 1990;37:125-8.
8. Waggoner ES, Mittendorf R, Biney N, Herbest LA. Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vagina clear-cell adenocarcinoma. Gynecol Oncol 1994;55:238-44.
9. Sistema Nacional de Salud. Boletín de información y estadística, daños a la salud, 1998;18(2):338.
10. Sistema Nacional de Salud. Anuario estadístico de los servicios de salud y los servicios de salud de los estados, 1999;pp:113.
11. Schrager S, Potter EB. Diethylstilbestrol exposure. Am Fam Physician 2004;69(10):2395-400.
12. Herbst AL, Scully ER. Adenocarcinoma of the vagina in adolescence. Cancer 1970;25:745-57.
13. Kruse N, Lauver D, Hanson K. Clinical implications of DES. Nurse Pract 2003;28(7):26-35.
14. Hammes B, Laitman CJ. Diethylstilbestrol (DES) update: recommendations for the identification and management of DES-exposed individuals. J Midwifery Womens Health 2003;48(1):19-29.
15. BC Cancer Agency. Care and research. Diethylstilbestrol. http://www.bccancer.beca/HPI/DrugIndexPro/Diethylstilbestrol.htm
16. a ed. Elsevier Science, 2003;pp:499-503.
17. González-Merlo J. Oncología ginecológica. Salvat Editores, 1991;pp:605-803.
18. Scully RE, Welch WR. Pathology of the female genital tract after prenatal exposure to dietihylstilbestrol. In: Herbst AL, Bern HA, editors. Developmental effects of diethylstilbestrol (DES) in pregnancy. New York: Thieme Stratton, 1981;p:26.
19. Mock U, Kucera H, Fellner C, Hendrik KT, Potter R. High-dose-rate (HDR) brachytherapy with or without external beam radiotherapy in the treatment of primary vaginal carcinoma: long-term results and side effects. Int J Radiat Oncol Biol Phys 2003;56(4):950-7.
20. Griffiths MJ, Murray KH, Phyllis RC. Oncología básica, fisiopatología, evaluación y tratamiento. La Prensa Médica Mexicana, 1998;pp:451-5.
21. Senekjian E, Frey K, Anderson D, et al. Local therapy in stage I clear cell adenocarcinoma of the vagina. Cancer 1987;60:1319.
22. Senekjian E, Frey K, Stone C, et al. An evaluation of stage II vaginal clear cell adenocarcinoma according to sub stage. Gynecol Oncol 1988;31:56.
23. nd ed. JB Lippincott Co, 1992;pp:1258-72.
24. Thigpen T, Blessing J, Homesley HD, et al. Phase II trial of cisplatin in advanced or recurrent cancer of the vagina. Cancer Treat Rep 1987;71:869.